NCT00430599View on ClinicalTrials.gov

The Effect of Levetiracetam (Keppra) on the Treatment of Tremor in Multiple Sclerosis

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

February 28, 2007

Study Completion Date

September 30, 2009

Conditions
Multiple Sclerosis
Trial Locations (1)

NE1 4LP

Sir James Spence Institute, Royal Victoria Infirmary, Newcastle

All Listed Sponsors
lead

Newcastle-upon-Tyne Hospitals NHS Trust

OTHER

NCT00430599 - The Effect of Levetiracetam (Keppra) on the Treatment of Tremor in Multiple Sclerosis | Biotech Hunter | Biotech Hunter